Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - Zynerba Pharmaceuticals, Inc. | a17-1406_1ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15 (d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 6, 2017
ZYNERBA PHARMACEUTICALS, INC.
(Exact Name of Issuer as Specified in Charter)
Delaware |
|
001-37526 |
|
26-0389433 |
(State or Other Jurisdiction of |
|
(Commission |
|
(I.R.S. Employer |
80 W. Lancaster Avenue, Suite 300
Devon, PA 19333
(Address of Principal Executive Offices)
(484) 581-7505
(Registrants Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
Attached as Exhibit 99.1 is a presentation that Zynerba Pharmaceuticals, Inc. will use during the J.P. Morgan 35th Annual Healthcare Conference in San Francisco, California on January 9, 2017 through January 12, 2017, and may use from time to time in presentations or discussions with investors, analysts and other parties.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit |
|
Document |
|
|
|
99.1 |
|
Zynerba Pharmaceuticals, Inc. Presentation. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 6, 2017 |
| |
|
| |
|
ZYNERBA PHARMACEUTICALS, INC. | |
|
|
|
|
By: |
/s/ Suzanne Hanlon |
|
|
Name: Suzanne Hanlon |
|
|
Title: Secretary, General Counsel and Vice President, Human Resources |